Iovance Biotherapeutics, Inc.
IOVA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$372 | -$444 | -$396 | -$342 |
| Dep. & Amort. | $44 | $33 | $21 | $14 |
| Deferred Tax | -$3 | -$3 | $0 | $0 |
| Stock-Based Comp. | $110 | $63 | $84 | $70 |
| Change in WC | -$123 | -$7 | -$3 | $25 |
| Other Non-Cash | -$9 | -$4 | $1 | $6 |
| Operating Cash Flow | -$353 | -$362 | -$293 | -$228 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$11 | -$22 | -$20 | -$38 |
| Net Acquisitions | -$53 | -$213 | -$277 | -$38 |
| Inv. Purchases | -$461 | -$206 | -$246 | -$725 |
| Inv. Sales/Matur. | $428 | $286 | $523 | $763 |
| Other Inv. Act. | $0 | $0 | $277 | $38 |
| Investing Cash Flow | -$96 | -$155 | $256 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $1 |
| Stock Issued | $397 | $463 | $190 | $203 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$7 | -$0 | $1 | $35 |
| Financing Cash Flow | $391 | $463 | $190 | $239 |
| Forex Effect | -$1 | -$3 | $0 | $0 |
| Net Chg. in Cash | -$59 | -$57 | $154 | $11 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $181 | $238 | $84 | $73 |
| End Cash | $122 | $181 | $238 | $84 |
| Free Cash Flow | -$364 | -$384 | -$313 | -$266 |